.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
What You Should Know: – Forcura, an intelligent workflow management company, an...
What You Should Know: – Linus Health has introduced Anywhere for Health Systems...
Alnylam will likely face challenges in turning a profit this year, despite execu...
The company unveiled TxGemma, a collection of Gemma-based open models aimed at i...
An annual gathering of industry and government officials focused on biomedical c...
A study published in medRxiv reveals that inference techniques including chain-o...
Amvuttra, an Alnylam drug approved to treat nerve pain from transthyretin amyloi...
GE HealthCare's global product marketing director, Peter Eggleston, sat down wit...
Chimerix began attracting deal interest in its experimental brain tumor treatmen...
Happy Friday everyone! We’re happy you made it through another week. That mean...
Novartis’ Fabhalta notched another FDA approval, this time in adults with an ult...
AstraZeneca is again boosting its manufacturing footprint in China, this time ma...
+Plus, news about Autolus, MacroGenics and BlissBio: Akeso bispecific looks ...
AstraZeneca is again boosting its manufacturing footprint in China, this time sp...
AstraZeneca is further investing in China, opening an R&D center in Beijing and ...